Deferred Income Tax Expense (Benefit) of CITIUS ONCOLOGY, INC. from 30 Sep 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
CITIUS ONCOLOGY, INC. quarterly and annual Deferred Income Tax Expense (Benefit) in USD history and change rate from 30 Sep 2023 to 31 Dec 2025.
  • CITIUS ONCOLOGY, INC. Deferred Income Tax Expense (Benefit) for the quarter ending 31 Dec 2025 was $264,240, unchanged year-over-year.
  • CITIUS ONCOLOGY, INC. annual Deferred Income Tax Expense (Benefit) for 2025 was $1,056,960, a 84% increase from 2024.
  • CITIUS ONCOLOGY, INC. annual Deferred Income Tax Expense (Benefit) for 2024 was $576,000, unchanged from 2023.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)

CITIUS ONCOLOGY, INC. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $264,240 $0 0% 01 Oct 2025 31 Dec 2025 10-Q 13 Feb 2026 2026 Q1
Q4 2024 $264,240 +$120,240 +84% 01 Oct 2024 31 Dec 2024 10-Q 13 Feb 2026 2026 Q1
Q4 2023 $144,000 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025 2025 Q1

CITIUS ONCOLOGY, INC. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,056,960 +$480,960 +84% 01 Oct 2024 30 Sep 2025 10-K 23 Dec 2025 2025 FY
2024 $576,000 $0 0% 01 Oct 2023 30 Sep 2024 10-K 23 Dec 2025 2025 FY
2023 $576,000 01 Oct 2022 30 Sep 2023 10-K 27 Dec 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.